MK-6913

MK-6913 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-6913, covering 2016-05-04 to 2016-05-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-6913 for the Treatment of Hot Flashes in Postmenopausal Women (6913-004) [Phase 2]